Market Cap (In AUD)
11.34 Million
Revenue (In AUD)
14.52 Thousand
Net Income (In AUD)
-1.17 Million
Avg. Volume
105.83 Thousand
- Currency
- AUD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.045-0.11
- PE
- -
- EPS
- -
- Beta Value
- 1.606
- ISIN
- AU0000197352
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Dr. Peter Laurence Molloy BSc, FAICD, MBA
- Employee Count
- -
- Website
- https://www.firebrickpharma.com
- Ipo Date
- 2022-01-27
- Details
- Firebrick Pharma Limited engages in the development and commercialization of nasal spray treatment for the common cold under the Nasodine name in Australia. The company was incorporated in 2012 and is based in Melbourne, Australia.
More Stocks
-
6117
-
SUNI
-
6775
-
BCONCEPTSBrand Concepts Limited
BCONCEPTS
-
FACT
-
POS
-
STBAS&T Bancorp, Inc.
STBA
-
CHEMPLASTSChemplast Sanmar Limited
CHEMPLASTS